HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elena K Schneider-Futschik Selected Research

Polymyxins (Polymyxin)

12/2020Effective Strategy Targeting Polymyxin-Resistant Gram-Negative Pathogens: Polymyxin B in Combination with the Selective Serotonin Reuptake Inhibitor Sertraline.
6/2020Metabolomic Description of Ivacaftor Elevating Polymyxin B Mediated Antibacterial Activity in Cystic Fibrosis Pseudomonas aeruginosa.
1/2020Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens.
1/2019Molecular Mechanisms of Neurotoxicity Induced by Polymyxins and Chemoprevention.
11/2018Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
1/2018Mechanistic Insights From Global Metabolomics Studies into Synergistic Bactericidal Effect of a Polymyxin B Combination With Tamoxifen Against Cystic Fibrosis MDR Pseudomonas aeruginosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elena K Schneider-Futschik Research Topics

Disease

12Cystic Fibrosis (Mucoviscidosis)
01/2022 - 01/2018
6Infections
07/2021 - 11/2018
2Pneumonia (Pneumonitis)
06/2022 - 07/2021
2Asthma (Bronchial Asthma)
11/2021 - 10/2021
2Bacterial Infections (Bacterial Infection)
05/2020 - 01/2020
1Inflammation (Inflammations)
06/2022
1Liver Diseases (Liver Disease)
01/2022
1Hyperthermia
07/2021
1Central Nervous System Infections (Central Nervous System Infection)
12/2020
1Ebola Hemorrhagic Fever
11/2019
1Dehydration (Water Stress)
11/2019
1Seizures (Absence Seizure)
01/2019
1Dizziness (Lightheadedness)
01/2019
1Confusion (Bewilderment)
01/2019
1Paresthesia (Dysesthesia)
01/2019
1Ataxia (Dyssynergia)
01/2019
1Hallucinations (Hallucination)
01/2019
1Vertigo (Positional Vertigo)
01/2019
1Mitochondrial Diseases (Mitochondrial Disease)
01/2019

Drug/Important Bio-Agent (IBA)

7Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
01/2022 - 01/2019
6ivacaftorIBA
06/2022 - 06/2020
6Polymyxins (Polymyxin)IBA
12/2020 - 01/2018
4Polymyxin B (Aerosporin)FDA LinkGeneric
06/2020 - 01/2018
3Anti-Bacterial Agents (Antibiotics)IBA
05/2020 - 11/2018
2Drug CombinationsIBA
01/2021 - 10/2020
2ivacaftor drug combination lumacaftorIBA
01/2021 - 01/2019
2Pharmaceutical PreparationsIBA
10/2020 - 05/2020
2teixobactinIBA
05/2020 - 01/2020
2Colistin (Coly-Mycin)FDA Link
01/2019 - 11/2018
1CytokinesIBA
06/2022
1LipopolysaccharidesIBA
06/2022
1lumacaftorIBA
01/2022
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
10/2021
1Drug CarriersIBA
07/2021
1Sertraline (Zoloft)FDA LinkGeneric
12/2020
1ivacaftor drug combination tezacaftorIBA
10/2020
1elexacaftorIBA
10/2020
1tezacaftorIBA
10/2020
1Ion Channels (Ion Channel)IBA
02/2020
1PhenothiazinesIBA
01/2020
1Oxygen (Dioxygen)IBA
11/2019
1VaccinesIBA
11/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1octapeptin antibioticsIBA
11/2018
1LipopeptidesIBA
11/2018
1Selective Estrogen Receptor Modulators (SERM)IBA
01/2018
1TamoxifenFDA LinkGeneric
01/2018

Therapy/Procedure

6Therapeutics
07/2021 - 11/2018
1Pain Management
11/2019